Compare Autozone Inc (AZO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Autozone Inc vs Medpace Holdings Inc — how do they compare? Autozone Inc trades at $3,025.08 (market cap $49.67B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Autozone Inc is far larger — about 2.9× Medpace Holdings Inc's market cap, and Autozone Inc is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| AZO | MEDP | |
|---|---|---|
Market Cap | $49.67B | $16.90B |
Sector | Consumer Cyclical | Technology |
52-Week High | $4.35K | $620.59 |
52-Week Low | $2.92K | $393.42 |
Enterprise Value | $62.05B | $16.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Autozone Inc
AutoZone is the premier seller of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in the United States. The company derives an increasing proportion of its sales from domestic commercial customers, although its presence in its home market is still dominated by its do-it-yourself operation, which accounts for nearly 75% of sales in country. AutoZone also has a growing presence in Mexico and Brazil. AutoZone had 6,767 stores in the U.S. (6,051), Mexico (664), and Brazil (52) as of the end of fiscal 2021.
Read more on AZO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
